Advanced Enzyme Technologies logo

Advanced Enzyme Technologies financials: balance sheet, profit and loss, cash flow

NSE: ADVENZYMESBSE: 540025Pharmaceuticals & BiotechnologySmall Cap

Advanced Enzyme Technologies Limited · Face value ₹2 · Listed Aug 2016 · Issue price ₹896
Last close ₹263.55down ₹0.60 (0.23%)BSE ₹262.95

Share price at the NSE close on 30 Oct 2026. Previous close ₹264.15.

30 Oct: open ₹266.00, high ₹268.05, low ₹259.50

52-week range of traded prices to 30 Oct 2026
₹246.80Low, 26 Oct 2026₹419.00High, 11 May 2026
Market cap
₹2,929 Cr912th largest listed
P/E
17.14
P/B
1.76
Dividend yield
0.51%
ROE
10.9%
ROCE
11.2%
Debt to equity
0.01
Volume, NSE
1,81,29158.4% delivered

Advanced Enzyme Technologies' financial statements for the 10 years to Mar 2026, consolidated: the company and its subsidiaries together, with the half year to Sep 2026 after them.

10 years at a glance

₹ crore, years to March.Advanced Enzyme Technologies annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
33191Mar 1739694Mar 1842011628Mar 1944413317Mar 2050215115Mar 2152912411Mar 2254110413Mar 2362413725Mar 2463713422Mar 2574617421Mar 26
Peak revenue ₹746 Cr, year to Mar 2026; lowest ₹331 Cr, year to Mar 2017

Operating and net margin, per cent

  • Operating margin
  • Net margin
46.1%19.2%45.5%41.4%43.4%45.6%46.1%38.0%28.9%32.8%30.5%30.7%27.4%23.6%27.6%30.0%30.2%23.4%19.2%22.0%21.0%23.3%Mar 17Mar 19Mar 21Mar 23Mar 25Mar 26

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 2.3% of operating profit in the first full year.

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue746
  2. Materials and goods−193
  3. Employee costs−162
  4. Other expenses−161
  5. Operating profit229
  6. Depreciation−40
  7. Other income+35
  8. One-off items+11
  9. Finance costs−2.6
  10. Profit before tax233
  11. Tax−59
  12. Net profit174

What the company owns

  • Plant, investments and other assets₹817 Cr
  • Current investments₹584 Cr
  • Inventory₹177 Cr
  • Receivables₹145 Cr
  • Cash and bank₹116 Cr

What pays for it: net worth and liabilities

  • Net worth₹1,683 Cr
  • Other liabilities₹95 Cr
  • Owed to suppliers₹40 Cr
  • Borrowings₹21 Cr

Profit and loss

Consolidated, ₹ crore, years to March. The last column is the twelve months to Sep 2026, the latest four quarters added.Advanced Enzyme Technologies quarterly results

₹ croreMar 2017Mar 2018Mar 2019Mar 2020Filed 30 MayMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 13 MayMar 2026Sep 2026Twelve months
Revenue from operations331396420444502529541624637746780
181232238242270328384419442517544
Materials and goods bought6881778199110132145152193204
Employee costs51–808087104115128142162168
Other expenses61–808184114138146149161171
Operating profit before depreciation151164182202232201156204194229236
Operating margin45.5%41.4%43.4%45.6%46.1%38.0%28.9%32.8%30.5%30.7%30.2%
Materials, % of revenue20.5%–18.4%18.2%19.7%20.7%24.4%23.2%23.8%25.9%26.2%
Employee costs, % of revenue15.5%–19.1%18.1%17.4%19.6%21.2%20.6%22.2%21.8%21.6%
Other expenses, % of revenue18.5%–19.1%18.1%16.8%21.6%25.4%23.5%23.4%21.6%22.0%
Depreciation and amortisation1218212628353535374041
Operating profit after depreciation138146161177203166121169158189194
Other income2156962537333537
Finance costs48432223433
Profit before one-off items and tax137139162179210171144203187221229
One-off items000000−4−1501111
Profit before tax137139162179210171140188187233240
–45464659473751535962
Share of profit of joint ventures and associates––––––––––0
9194116133151124104137134174178
Other comprehensive income––1439−1017559199573
Total comprehensive income––130173142140158146153268251
Net margin27.4%23.6%27.6%30.0%30.2%23.4%19.2%22.0%21.0%23.3%22.9%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2018 they do not, so they are left blank. Tax is left blank for the year to Mar 2017: profit before tax less the tax charge stated does not come to the profit after tax the same statement states, so the tax charge is not shown. Belonging to the company's shareholders is left blank for the year to Mar 2017: the filing's earnings per share does not match the profit it states, and cannot be multiplied back into the owners' profit because a split, bonus or rights issue between the start of the period and the filing changed the share count the earnings per share is on.

Balance sheet

Consolidated, ₹ crore, at 31 March. The last column is the half year to Sep 2026, after the latest full year: the balance sheet at its end.

₹ croreMar 2019Mar 2020Filed 30 MayMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 13 MayMar 2026Sep 2026Half year
7058671,0311,1401,2841,3711,4691,6831,720
6798409711,0891,2351,3241,4211,6321,665
Share capital222222222222222222
Reserves6578179481,0661,2131,3021,3981,6101,643
Belonging to outside owners of subsidiaries262860524947485155
281715111325222122
656068607810697107117
364654676058564969
Liabilities going with businesses held for sale55–––––––
8119791,1531,2681,4221,5351,6211,8391,906
524598637663700726741795863
2823765166047228108801,0441,043
Net debt−106−190−305−365−470−521−566−679−651
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March. The last column is the half year to Sep 2026, after the latest full year: the cash flow over its six months.

₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 13 MayMar 2026Sep 2026Half year
16312414014114215777
223175183201202238117
−15−271−30−12−29−23
Receivables−7−1−101−18−267
Inventories−8−261−24−8−16−25
Payables136−41195
Other working capital−1−34−312−7−10
Tax paid−57−55−37−49−60−65−31
Interest paid2223032
Capital spending19283842345252
Free cash flow143951029910910526
−26−26−298−65−89−7444
−26−27−26−59−73−70−72
Dividends paid8–1357596016
Shares bought back00000052
Shares issued0000010
Net change in cash11170−18417−191249
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020. Dividends paid is left blank for the year to Mar 2022: the cash-flow statement states no dividends paid, while the company's own dividend record shows one paid in the period, so the line is not given.

Per share

Consolidated, ₹ per share, years to March.Advanced Enzyme Technologies dividend history

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Filed 30 MayMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 13 MayMar 2026
Earnings per share₹40.95₹8.07₹9.95₹11.58₹13.09₹10.70₹9.45₹11.92₹11.72₹15.08
Diluted earnings per share₹40.93₹8.06₹9.94₹11.56₹13.07₹10.68₹9.45₹11.92₹11.71₹15.06
Dividend per share₹0.40₹0.50₹0.60₹0.60₹0.90₹1.00₹5.00₹5.10₹5.20₹1.35
Book value per share––₹60.80₹75.18₹86.88₹97.43₹110.45₹118.41₹127.00₹145.81
Dividend payout–6.0%6.0%5.2%6.9%9.3%52.9%42.8%44.4%9.0%
Shareholder yield––––0.2%–0.5%1.5%1.9%2.1%
Market cap at the year end (₹ crore)4,5982,3802,0391,5913,8543,1542,5943,8973,1272,857
Shareholder yield is left blank for the year to Mar 2022: the cash-flow statement states no dividends paid, while the company's own dividend record shows one paid in the period, so the line is not given.

Ratios

Consolidated, years to March.Advanced Enzyme Technologies PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Mar 2020Filed 30 MayMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 13 MayMar 2026
Revenue growth–19.4%6.0%5.8%13.0%5.5%2.1%15.4%2.1%17.1%
Operating profit growth–8.8%11.0%11.2%14.4%−13.0%−22.3%30.7%−4.9%17.8%
Net profit growth–3.2%23.9%14.8%13.8%−18.3%−16.1%31.9%−2.2%29.6%
Earnings per share growth–−80.3%23.3%16.4%13.0%−18.3%−11.7%26.1%−1.7%28.7%
––16.4%17.0%16.2%11.6%9.1%10.4%9.6%11.1%
–––0.7 pts−0.9 pts−4.5 pts−2.5 pts1.3 pts−0.9 pts1.5 pts
From the net margin–––1.6 pts0.0 pts−3.6 pts−1.6 pts0.9 pts−0.4 pts0.9 pts
From asset turnover–––−0.7 pts−0.9 pts−0.9 pts−0.8 pts0.5 pts−0.4 pts0.7 pts
From borrowing–––−0.2 pts0.0 pts0.0 pts−0.1 pts0.0 pts0.0 pts−0.2 pts
Return on capital employed––21.9%20.0%19.4%14.5%9.4%12.1%10.6%11.1%
Cash conversion––––107.5%99.8%135.1%103.2%106.4%90.3%
Interest cover33.218.041.558.2127.492.750.257.844.471.9
Debt to equity––0.040.020.010.010.010.020.010.01
Receivable days––5161636168586671
Inventory days––363361346402343375378335
Payable days––4643566067404176
Cash conversion cycle, days––369379353404344393403331
Working capital days––9010098118113102119122
Asset turnover––0.520.500.470.440.400.420.400.43
Assets per rupee of net worth––1.191.181.181.181.161.161.151.13
Sales per rupee of plant––2.592.122.112.021.982.262.172.70
Capital spending to depreciation––––0.680.801.091.200.921.30
Plant being built, % of plant in use––2.9%2.3%2.1%3.7%5.7%11.1%7.4%18.6%
No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
9.8%
Cash from operations against operating profit
68.4%
Measure10 years5 years3 years
Revenue growth, yearly rate–8.2%11.3%
Profit growth, yearly rate–2.9%16.9%
Return on equity, average–10.3%10.3%
Return on capital employed, average–11.5%11.3%
Operating margin, average38.3%32.2%31.3%
Net margin, average24.8%21.8%22.1%
Asset turnover, average–0.420.42
Cash conversion cycle, days, average–375375
Interest cover, average59.563.458.0
Debt to equity, average–0.010.02

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations705441157
Cash from investing−552−228−74
Cash from financing−255−202−70
Capital spending19512852
Dividends paid–17660
Shares bought back000
Shares issued for cash211
Borrowings raised660
Borrowings repaid24151

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––444846
Altman Z-scorePublished threshold 1.81––14.1611.2221.6317.4213.7616.7814.8613.68
Beneish M-scorePublished threshold −1.78––––−2.39−2.46−2.53−2.61−2.32−2.18
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––1.372.1819.464.075.115.26
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––1.131.111.130.99
Receivables growth less revenue growthOur threshold 0 percentage points–––21.372.48−3.2511.63−17.1614.998.58
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––−0.68−5.1018.02−17.5910.040.92−14.36
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––0.520.500.55−0.900.240.450.29
Assets under construction, years of additionsOur threshold 2 years of additions–––0.060.090.160.340.800.412.23
Effective tax ratePublished threshold 17.16 per cent32.3832.6828.4425.7428.0027.6326.0227.0828.5025.34
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––−4.25−0.080.87−3.35−2.67
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
30 Apr 2026CRISIL Ratings LimitedBank FacilitiesCrisil A+Review, Re-affirmStable12.50
30 Apr 2026CRISIL Ratings LimitedBank FacilitiesCrisil A1+Review, Re-affirm2.50
13 Feb 2026ICRA LimitedNon-fund based-Others[ICRA]A1+New, New15
13 Feb 2026ICRA LimitedFund-based-Cash credit[ICRA]AA-New, NewStable40
13 Feb 2026ICRA LimitedUnallocated limits-Unallocated limits[ICRA]AA- /[ICRA]A1+New, NewStable45
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.